Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 57

Results For "NIT"

6327 News Found

Gujarat Themis Biosyn acquires MicroBiopharm Japan for Rs. 1,300 Cr
News | May 23, 2026

Gujarat Themis Biosyn acquires MicroBiopharm Japan for Rs. 1,300 Cr

Transition to a fermentation-based globally integrated CDMO platform


Alembic Pharma receives USFDA nod for generic Levothyroxine sodium tablets
Drug Approval | May 22, 2026

Alembic Pharma receives USFDA nod for generic Levothyroxine sodium tablets

Approved product is therapeutically equivalent to Synthroid of AbbVie and is indicated for the treatment of congenital or acquired hypothyroidism


Eli Lilly appoints Chandan S. as Senior Director for Data Science and AI Engineering
People | May 22, 2026

Eli Lilly appoints Chandan S. as Senior Director for Data Science and AI Engineering

AI and analytics leader brings extensive expertise in machine learning, GenAI, and life sciences decision intelligence to Lilly’s data science operations


Aurobindo Pharma Q4 FY26 revenue rises 5.6% to Rs. 8,853 crore
News | May 22, 2026

Aurobindo Pharma Q4 FY26 revenue rises 5.6% to Rs. 8,853 crore

Net profit stood at Rs. 921 crore for the quarter, while Europe revenues surged 30.2% YoY to Rs. 2,795 crore


Multimodal AI emerges as next leap in predictive healthcare: Ashwattha Sahasrabuddhe, Principal Architect and Technology & Practice Head – Healthcare Business, Tata Elxsi
Opinion | May 22, 2026

Multimodal AI emerges as next leap in predictive healthcare: Ashwattha Sahasrabuddhe, Principal Architect and Technology & Practice Head – Healthcare Business, Tata Elxsi

Organizations that embrace it thoughtfully today will help shape a healthier tomorrow, for India and beyond


Venus Remedies secures global approval for Plerixafor in Saudi Arabia
Drug Approval | May 22, 2026

Venus Remedies secures global approval for Plerixafor in Saudi Arabia

SFDA nod marks company’s strategic entry into high-value specialty oncology injectables as it targets expanding stem cell transplant and haemato-oncology market in the GCC region


Boehringer Ingelheim India signs MoUs with NIPER Ahmedabad and Hyderabad to expand research collaboration
R&D | May 21, 2026

Boehringer Ingelheim India signs MoUs with NIPER Ahmedabad and Hyderabad to expand research collaboration

This collaboration across the NIPER network- Raebareli, Hajipur, Ahmedabad and Hyderabad is strengthening translational research and opnMe access


QIAGEN and NVIDIA partner on AI drug discovery
R&D | May 21, 2026

QIAGEN and NVIDIA partner on AI drug discovery

Collaboration integrates NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights’ curated biomedical knowledge bases


Hansa Biopharma licenses IDEFIRIX to SERB Pharmaceuticals in €115 million deal
News | May 21, 2026

Hansa Biopharma licenses IDEFIRIX to SERB Pharmaceuticals in €115 million deal

SERB has a substantial European commercial presence and a successful track record in critical care and rare disease commercialization


India reaffirms commitment to global women and child health agenda at WHA 2026
Policy | May 21, 2026

India reaffirms commitment to global women and child health agenda at WHA 2026

Minister J.P. Nadda holds bilateral meeting with Helen Clark, Board Chair of the Partnership for Maternal, Newborn and Child Health in Geneva